Actinium Pharmaceuticals Inc (ATNM)

[extrooper]

I’m still amazed at the lack of market penetration for afrezza. The lack of interest in biotech from traders is one thing, the lack of interest by investors in biotech is appalling and the lack of acclaim by the medical community is disgusting. The lack of media support, is the lack of actual reporting of any news in the media, but plenty of slander abounds.